Topical Methotrexate Therapy for Psoriasis
Weinstein et al.
Arch Dermatol 1989;125:227-230.
ABSTRACT
Pancytopenia Following Low-Dose Oral Methotrexate Therapy for Psoriasis
Shupack and Webster
JAMA 1988;259:3594-3596.
ABSTRACT
Commentary: Three Decades of Folic Acid Antagonists in Dermatology
Weinstein
Arch Dermatol 1983;119:525-527.
ABSTRACT
A Clinical Screening Program for Topical Chemotherapeutic Drugs in Psoriasis
Weinstein et al.
Arch Dermatol 1981;117:388-393.
ABSTRACT
Hypersensitivity Reactions to Cancer Chemotherapeutic Agents
WEISS and BRUNO
ANN INTERN MED 1981;94:66-72.
ABSTRACT
Drugs Five Years Later: Methotrexate
WEINSTEIN
ANN INTERN MED 1977;86:199-204.
ABSTRACT
An Appraisal of Current Systemic Chemotherapy for Psoriasis
Farber et al.
Arch Dermatol 1976;112:1679-1688.
ABSTRACT
Effects of Methotrexate Esters on Normal and Psoriatic Skin
Weinstein and McCullough
Arch Dermatol 1975;111:471-475.
ABSTRACT
Hepatotoxicity of Long-Term Methotrexate Therapy for Psoriasis
Tobias and Auerbach
Arch Intern Med 1973;132:391-396.
ABSTRACT
Psoriasis-Liver-Methotrexate Interactions
Weinstein et al.
Arch Dermatol 1973;108:36-42.
ABSTRACT
Methotrexate: Mechanism of Action on DNA Synthesis in Psoriasis
Weinstein et al.
Arch Dermatol 1971;104:236-243.
ABSTRACT
Blood Levels of Methotrexate and the Treatment of Psoriasis
Halprin et al.
Arch Dermatol 1971;103:243-249.
ABSTRACT
Hepatotoxicity of Methotrexate the Treatment of Psoriasis
Roenigk et al.
Arch Dermatol 1971;103:250-261.
ABSTRACT
Methotrexate for Psoriasis: A New Therapeutic Schedule
Weinstein and Frost
Arch Dermatol 1971;103:33-38.
ABSTRACT
Pityriasis Rubra Pilaris: Prolonged Treatment With Methotrexate
Knowles and Chernosky
Arch Dermatol 1970;102:603-612.
ABSTRACT
Evaluation of Possible Chronic Hepatotoxicity From Methotrexate for Psoriasis
Weinstein et al.
Arch Dermatol 1970;102:613-618.
ABSTRACT
Hydroxyurea: A New Treatment for Psoriasis
Leavell and Yarbro
Arch Dermatol 1970;102:144-150.
ABSTRACT
Failure of Leucovorin "Rescue" in Methotrexate Treatment of Psoriasis
Cipriano et al.
Arch Dermatol 1970;101:651-652.
ABSTRACT
Cirrhosis Caused by Methotrexate in the Treatment of Psoriasis
Muller et al.
Arch Dermatol 1969;100:523-530.
ABSTRACT
Treatment of Psoriasis With Minute Divided Oral Doses of Methotrexate
Spiro and Demis
Arch Dermatol 1969;99:459-464.
ABSTRACT
Oral Florid Papillomatosis Complicated by Verrucous Squamous Carcinoma: Treatment With Methotrexate
Kanee
Arch Dermatol 1969;99:196-202.
ABSTRACT
Methotrexate for Psoriasis in Weekly Oral Doses
Roenigk et al.
Arch Dermatol 1969;99:86-93.
ABSTRACT
Folate Losses From the Skin in Exfoliative Dermatitis
Hild
Arch Intern Med 1969;123:51-54.
ABSTRACT
Topical Methotrexate in Psoriasis
Fry and McMinn
Arch Dermatol 1967;96:483-488.
ABSTRACT
Methotrexate for Psoriasis
REES et al.
Arch Dermatol 1967;95:2-11.
ABSTRACT
Pityriasis Rubra Pilaris: Treatment With Folic Acid Antagonists
BROWN and PERRY
Arch Dermatol 1966;94:636-638.
ABSTRACT
Human Low-Dosage Parenteral Methotrexate Therapy: A Controlled Toxicity Study
WRIGHT et al.
Arch Dermatol 1966;93:731-736.
ABSTRACT
Ingram Method of Treating Psoriasis
COMAISH
Arch Dermatol 1965;92:56-58.
ABSTRACT
Aminopterin for Psoriasis: A Decade's Observation
REES et al.
Arch Dermatol 1964;90:544-552.
ABSTRACT
Parenteral vs. Oral Folic Acid Antagonists
AUERBACH
Arch Dermatol 1964;90:553-557.
ABSTRACT